Galactooligosaccharide

Galactooligosaccharide-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).

Image View List View Download All PDFs Archive

loading
Methods for providing sialylated oligosaccharides
Rijksuniversiteit Groningen
March 23, 2017 - N°20170080002

The invention relates to a method for providing analogs of human milk oligosaccharides (hmo), in particular oligosaccharides containing terminal sialic acid. The method comprises the steps of: a) providing a source of non-digestible galactooligosaccharides (gos) containing at least two terminally bonded β-linked galactose residues; b) providing a sialic acid donor having (α2-3)-sialylated o-glycans; c) contacting ...
Methods of enhancing the gastrointestinal health of a companion animal
Mars, Incorporated
February 02, 2017 - N°20170027191

Disclosed herein are methods for enhancing the gastrointestinal health of a companion animal, comprising orally administering to the companion animal a composition comprising at least about 0. 25% of fermentable fiber by weight of the composition. Further disclosed herein are methods of improving the fecal odor of the feces of a companion animal, comprising orally administering to the companion animal a composition ...
Composition with synbiotics
N.v. Nutricia
November 24, 2016 - N°20160338397

Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed.
Galactooligosaccharide Patent Pack
Download + patent application PDFs
Galactooligosaccharide Patent Applications
Download + Galactooligosaccharide-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Galactooligosaccharide-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Oral rehydration compositions with galactooligosaccharides
Abbott Laboratories
August 04, 2016 - N°20160219916

The general inventive concepts are directed to compositions and methods for the prevention and treatment of dehydration. Provided herein are oral rehydration formulas (orf) having an acidic ph, and comprising a source of carbohydrate, a source of sodium, a source of citrate, and a source of an oligosaccharide.
A preparation method of galactooligosaccharides with enhanced galactosyllactose which is a ingredient of mother's milk
Neo Cremar Co., Ltd.
June 16, 2016 - N°20160168608

The present invention relates to a method of preparing galactooligosaccharides having % a galactosyllactose content of 40 wt % or more.
Galactooligosaccharide composition for use in preventing or treating cognitive dysfunction and emotional disturbances in neuropsychiatry ...
Clasado Inc
February 18, 2016 - N°20160045524

A galactooligosaccharide composition comprising a mixture of disaccharides, trisaccharides, a tetrasaccharide and a pentasaccharide for use in preventing or treating cognitive dysfunction and/or emotional disturbances in neuropsychiatric illnesses or ageing.
Galactooligosaccharide Patent Pack
Download + patent application PDFs
Galactooligosaccharide Patent Applications
Download + Galactooligosaccharide-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Galactooligosaccharide-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
Mead Johnson Nutrition Company
August 20, 2015 - N°20150231213

Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject ...
Modified galactooligosaccharides
Glycom A/s
July 02, 2015 - N°20150183816

The invention relates to a method for making modified galactooligosaccharides comprising the step of enzymatic glycosylation, the modified galactooligosaccharides obtainable by the method and consumable products containing them.
Treatment of conditions associated with mycotoxin exposure
N.v. Nutricia
June 18, 2015 - N°20150164931

We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligosaccharide and/or fructooligosaccharide. The non-digestible oligosaccharide may comprise a short chain galacto-oligosaccharide (scgos) and/or short chain fructooligosaccharide (scfos). The trichothecene mycotoxin exposure associated condition may be associated with exposure to deoxynivalenol.
Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
Mead Johnson Nutrition Company
April 30, 2015 - N°20150119322

Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject ...
Nutritional compositions containing synergistic combination and uses thereof
Mead Johnson Nutrition Company
February 05, 2015 - N°20150037455

A composition and method for enhancing brain development in a pediatric subject, the method including administering to the pediatric subject a nutritional composition having up to about 7 g/100 kcal of a fat or lipid source, wherein the fat or lipid source includes at least about 0. 5 mg/100 kcal of milk or non-milk polar lipids; up to about 5 g/100 kcal of a ...
Methods for providing sialylated oligosaccharides
Mead Johnson Nutrition Company
November 13, 2014 - N°20140336140

The invention relates to a method for providing analogs of human milk oligosaccharides (hmo), in particular oligosaccharides containing terminal sialic acid. The method comprises the steps of: a) providing a source of non-digestible galactooligosaccharides (gos) containing at least two terminally bonded β-linked galactose residues; b) providing a sialic acid donor having (α2-3)-sialylated o-glycans; c) contacting ...
Composition with synbiotics
Mead Johnson Nutrition Company
October 16, 2014 - N°20140308391

Nutritional compositions with health benefits comprising bacterial strains and galactooligosaccharides are disclosed.
Galactooligosaccharide Patent Pack
Download + patent application PDFs
Galactooligosaccharide Patent Applications
Download + Galactooligosaccharide-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Galactooligosaccharide-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Process for preparing a functional fermented milk product with low acidity and containing a low ...
Mead Johnson Nutrition Company
August 14, 2014 - N°20140227393

The present invention relates to a process for preparing a functional fermented milk product with low acidity and containing a low content of lactose and enriched with galactooligosaccharide and bifidobacterium, and functional fermented milk product prepared therewith. The process is characterized by converting lactose in milk materials to galactooligosaccharide before subjecting the milk materials to lactic fermentation. The process is ...
Method for reducing the occurrence on infection in young children
Mead Johnson Nutrition Company
July 17, 2014 - N°20140200195

The invention pertains to the use of a composition in reducing the number of infections episodes and the occurrence of infections in young children, said composition comprising: (a) long chain polyunsaturated fatty acids, wherein the amount of arachidonic acid is less than 0. 06 gram per 100 gram fatty acid; and comprising, per 100 g fatty acids: (i) 0. 3-0. 6 gram docosahexaenoic acid; (ii) 0. 2-0. 4 ...
Boiled sugar sweet comprising non-fructosylated a-galactooligosaccharides
Mead Johnson Nutrition Company
July 03, 2014 - N°20140186513

The present invention concerns a hard candy comprising a mixture of sugars composed of glucose and non-fructosylated α-galacto-oligosaccharides in particular proportions. It also concerns a method of manufacturing said candies, as well as the utilization, for manufacturing a hard candy, of a composition that includes the aforementioned mixture.
Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome
Mead Johnson Nutrition Company
May 22, 2014 - N°20140142061

The present invention relates to the use of a galactooligosaccharide composition for preventing or reducing the risk of developing metabolic syndrome.
Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and ...
Mead Johnson Nutrition Company
March 27, 2014 - N°20140087021

The invention discloses an oligosaccharide mixture derived from cow's milk that can be easily spray dried comprising (a) a soluble oligosaccharide population which is the same as that of soluble oligosaccharides found in cow's milk and (b) β-galactooligosaccharides formed by the action of β-galacotsidase on lactose and the milk oligosaccharides. The mixture having a total monosaccharide ...
Agents to treat/prevent amoebiasis
Mead Johnson Nutrition Company
March 20, 2014 - N°20140079775

The invention provides formulations comprising isolated lacto-n-tetraose (lnt) or galactooligosaccharides (gos) or variants, isomers, analogs and derivatives thereof and a pharmaceutically acceptable carrier.